Delivery Order SPE2DB25D3201-SPE2DB25FNTVH
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $4,068.37 for the pharmaceutical product MYDAYIS ER 12.5 MG CAPSULE 100S. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award, with a ceiling value of $2,040.01, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MYDAYIS CAPS 25MG and is a firm fixed-price delivery order with an ultimate completion date of May 14, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $1,598.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 30, 2024. The contract covers the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of MYDAYIS ER 12.5 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, on July 23, 2024 with a ceiling value of $1,659.92 and an ultimate completion date of July 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not set-aside. Amerisourcebergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.41, is a delivery order (SPE2DX15D3017|SPE2DX24F0JKT) with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMNQW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,145.28 and a period of performance through April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.67 firm fixed-price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of April 25, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,960.37, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,246.01, is for the delivery of MYDAYIS CAPS 50MG, a prescription drug product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,226.81, is for the supply of 4568059545 MYDAYIS ER 12.5 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...